• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant

Helix Launches Clinico-Genomic Datasets to Accelerate Precision Medicine Drug Discovery

by Fred Pennic 06/07/2024 Leave a Comment

Helix Launches Clinico-Genomic Datasets to Accelerate Precision Medicine Drug Discovery

What You Should Know:  - Helix, a leader in population genomics, is launching new datasets designed to empower life science companies in developing precision medicine therapies.  - These comprehensive datasets, built through collaborations with various health systems, provide researchers with a rich resource for drug discovery and development across multiple disease areas. Unveiling the Power of Clinico-Genomic Data The datasets offer a unique combination of longitudinal
Read More

Tempus AI Files for IPO, Eyes Over $600M in Funding for AI-Powered Precision Medicine

by Fred Pennic 05/23/2024 Leave a Comment

Tempus AI Files for IPO, Eyes Over $600M in Funding for AI-Powered Precision Medicine

What You Should Know:  - Tempus AI, a leader in artificial intelligence (AI)-powered precision medicine, filed with the Securities and Exchange Commission (SEC) on Monday to raise up to $100M in an initial public offering (IPO). Industry analysts, however, believe this figure might be a placeholder, with the actual target amount closer to $600M. - Founded in 2015 and headquartered in Chicago, Illinois, Tempus AI reported $562M in revenue for the fiscal year ending March 31,
Read More

Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption

by Syed Hamza Sohail 05/16/2024 Leave a Comment

Phenomix Sciences Raises $7.8M to Accelerate Obesity Precision Medicine Adoption

What You Should Know: -              Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and Labcorp, and existing investors, including Health2047. -              The company has also been awarded a $2.3 million Phase II Small Business Innovation Research (SBIR) Grant
Read More

Zephyr AI Secures $111M to Democratize Precision Medicine with Explainable AI

by Fred Pennic 03/14/2024 Leave a Comment

Zephyr AI Secures $111M to Democratize Precision Medicine with Explainable AI

What You Should Know: - Zephyr AI, a healthcare technology company pioneering explainable AI (XAI) for precision medicine, raises $111M in Series A round led by Revolution Growth, Eli Lilly & Company, Jeff Skoll, and EPIQ Capital Group. - The company plans to use this round of funding to refine its technology to fortify its extensive collection of training and validation datasets, crucial for robust AI models, deliver results even faster, and expand its scientific and commercial
Read More

Sano Genetics Secures $11.4M to Turbocharge Precision Medicine Research

by Jasmine Pennic 01/22/2024 Leave a Comment

Sano Genetics Secures $11.4M to Turbocharge Precision Medicine Research

What You Should Know: - Sano Genetics, a software company that is revolutionizing precision medicine research, has secured $11.4M in new funding. - This latest investment, led by Plural with participation from existing investors MMC Ventures, Episode 1, and Seedcamp, brings the company's total funding to $22M. Revolutionizing Precision Medicine Research Founded by a trio of visionary minds - Patrick Short (CEO), Charlotte Guzzo (COO), and William Jones (CTO) - Sano Genetics is
Read More

Drug-Gene Interactions: Minimizing Risk with Pharmacogenomics

by Houda Hachad, PharmD, Vice President of Clinical Operations at Aranscia 08/10/2023 Leave a Comment

Drug-Gene Interactions: Minimizing Risk with Pharmacogenomics

Every individual responds differently to medications, and their reactions can vary greatly. While a specific drug may be effective for one person with no adverse effects, another individual may experience a negative reaction to the same medication. Pharmacogenomic (PGx) testing enables the identification of patients who are prone to adverse drug reactions, individuals who are more likely to benefit from specific medications and those who may require adjusted dosages. As adverse drug reactions
Read More

Prenosis Awarded $4.8M in NIH Grants to Enable Precision Medicine for Sepsis

by Jasmine Pennic 07/12/2023 Leave a Comment

Prenosis Awards $4.8M in NIH Grants to Enable Precision Medicine for Sepsis

What You Should Know:  Prenosis, Inc., a Chicago, IL-based AI company enabling precision medicine in acute care, announced today that it has been awarded two Phase 2 SBIR grants totaling $4.8M in funding by the National Institute of General Medical Sciences (NIGMS), a division of the National Institute of Health (NIH). The grants will study the use of Prenosis's Immunix™ Artificial Intelligence platform for acute immune states. Prenosis has built a collection of artificial
Read More

Expectations For The Connected Care Business In The Years Ahead

by Russ Johannesson, CEO at Glooko 05/02/2023 Leave a Comment

Expectations For The Connected Care Business In The Years Ahead

Though we seldom see their use in our modern world and, even then, only in fiction, there was a time when it was common for people to actually use things like crystal balls and divining rods to try to uncover unknown yet valuable information. As unbelievable as it may seem, soothsayers peered into crystal balls aiming to help seekers look into the future for guidance, while prospectors would rely earnestly on divining rods as they attempted to locate underground riches of water or oil. While
Read More

Phenomix Sciences Launches Saliva Test to Predict Obesity Phenotype

by Jasmine Pennic 03/30/2023 Leave a Comment

Phenomix Sciences Launches Saliva Test to Predict Obesity Phenotype

What You Should Know: - Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces today the launch of its first therapy selection test, the My Phenome Hungry Gut test. - This is a first-of-its-kind obesity test and will determine if a patient’s phenotype is Hungry Gut (Satiety) or feeling hungry shortly after eating a meal. If a patient is Hungry Gut phenotyped, providers are able to more precisely and
Read More

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response 

by Syed Hamza Sohail 03/29/2023 Leave a Comment

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response 

What You Should Know: Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the way diseases are diagnosed and treatment decisions are made.Taiwania Capital and Debiopharm Innovation Fund co-led the round, with participation from previous investors First Star Ventures, Redalpine Venture Partners, and Pikas. Other new investors include P5 Health
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 22
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |